Rhenman & Partners Asset Management AB - PORTOLA PHARMACEUTICALS INC ownership

PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 172 filers reported holding PORTOLA PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.

Quarter-by-quarter ownership
Rhenman & Partners Asset Management AB ownership history of PORTOLA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2018$4,723,000
-26.8%
241,964
-0.1%
0.54%
-16.5%
Q3 2018$6,453,000
-51.5%
242,302
-31.2%
0.65%
-52.5%
Q2 2018$13,306,000
+50.8%
352,302
+30.4%
1.36%
+25.2%
Q1 2018$8,826,000
-14.1%
270,248
+28.0%
1.09%
-21.7%
Q4 2017$10,279,000
-36.0%
211,153
-29.0%
1.39%
-32.3%
Q3 2017$16,069,000
+158.2%
297,400
+168.4%
2.05%
+129.4%
Q2 2017$6,224,000
+31.5%
110,805
-8.3%
0.89%
+19.2%
Q1 2017$4,734,000
+74.6%
120,8050.0%0.75%
+44.2%
Q4 2016$2,711,000
-99.9%
120,8050.0%0.52%
+19.3%
Q3 2016$2,743,482,000
+110613.6%
120,805
+15.1%
0.44%
-0.9%
Q2 2016$2,478,000
+15.7%
105,0000.0%0.44%
+3.5%
Q1 2016$2,142,000
-32.9%
105,000
+69.4%
0.42%
-11.8%
Q4 2015$3,190,000
+5.4%
62,000
-12.7%
0.48%0.0%
Q3 2015$3,026,000
-12.6%
71,000
-6.6%
0.48%
+15.9%
Q2 2015$3,462,00076,0000.42%
Other shareholders
PORTOLA PHARMACEUTICALS INC shareholders Q1 2016
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 1,220,672$52,025,0008.00%
Fernwood Investment Management, LLC 190,011$8,098,0007.10%
Cormorant Asset Management, LP 500,000$21,310,0003.40%
HARVEY CAPITAL MANAGEMENT INC 157,930$6,730,0002.69%
Atika Capital Management LLC 128,000$5,456,0002.68%
Redmile Group, LLC 769,641$32,802,0002.48%
Temasek Holdings (Private) Ltd 5,833,568$248,627,0002.36%
SECTORAL ASSET MANAGEMENT INC 1,088,118$46,376,0002.12%
Eventide Asset Management 479,900$20,453,0001.19%
BBT Capital Management, LLC 200,000$8,524,0000.79%
View complete list of PORTOLA PHARMACEUTICALS INC shareholders